-
CDC updates guidance on the use of respirators
01 February, 2022
People can choose to use N95s now that shortages are not a concern.....COVID-19
-
Pfizer/BioNTech seeks FDA approval for paediatric dose
United States // 01 February, 2022
Advisory committee to meet 15 February…COVID-19
-
Novavax seeks FDA approval
United States // 31 January, 2022
Fourth vaccine for the US if approved…COVID-19
-
Moderna gets FDA approval
United States // 31 January, 2022
Second COVID-19 vaccine to receive full authorisation in adults…COVID-19
-
Vaccine update - Pfizer/BioNTech vaccine open to 12 to 17 year olds
Malawi // 31 January, 2022
COVID-19 vaccination expanded to 12 years and olderCOVID-19
-
Vaccine Update – Pfizer/BioNTech approved for children aged 5 to 11 years
Qatar // 31 January, 2022
Health authorities have approved Pfizer/BioNTech to be used in children aged 5 to 11 years...COVID-19
-
COVID-19 from pet hamster and onward transmission
Hong Kong (China SAR) // 30 January, 2022
COVID-19 transmission from hamsters to humans and onward spreadCOVID-19
-
Hypotheses of Omicron origin
30 January, 2022
Theories on origin of OmicronCOVID-19
-
ECDC updates guidance on ending isolation for people with COVID-19
29 January, 2022
Focus on Omicron transmission and shortening isolation....COVID-19
-
Vaccinating parents may protect children from COVID-19
29 January, 2022
Parental vaccination confers protection to unvaccinated children against COVIDCOVID-19
-
Omicron Sub-Lineage BA.2 update
Denmark // India // South Africa // United Kingdom // 28 January, 2022
The variant is increasing in Denmark, India, South Africa and the United Kingdom....COVID-19
-
Higher risk of rehospitalisation and death following COVID-19 hospitalisation
28 January, 2022
People hospitalised due to COVID-19 are at a higher risk of rehospitalisation and death compared to general populationCOVID-19
-
COVID-19 vaccine update - Different vaccine brand as booster dose
Nepal // 28 January, 2022
Brand other than vero cell can be used as boosterCOVID-19
-
Third doses protect against hospitalisation
United States // 27 January, 2022
CDC study examines benefits of mRNA vaccine…COVID-19
-
European Medicines Agency recommends conditional approval for Paxlovid
27 January, 2022
EMA recommends conditional approval for Paxlovid...COVID-19
-
ECDC Assessment of the further emergence and potential impact of the SARS-CoV-2 Omicron variant of concern in the EU/EEA, 19th update
27 January, 2022
ECDC 19th update on SARS-CoV-2 and focus on Omicron VOC...COVID-19
-
Moderna begins trials for Omicron-specific booster shot
27 January, 2022
Moderna announced that it has begun phase two trials of a booster dose of its vaccine designed to target the Omicron variant...COVID-19
-
All COVID-19 restrictions to end on 31 January
Denmark // 26 January, 2022
COVID-19 no longer classified as “socially critical disease”…COVID-19
-
WHO COVID-19 Weekly Reports, January 2022
25 January, 2022
Summary of WHO weekly reports...COVID-19
-
Pfizer and BioNTech commence trial of Omicron specific vaccine
25 January, 2022
Pfizer and BioNTech commence variant specific vaccine trial...COVID-19